Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of Fair Value Hierarchy

At March 31, 2024, April 2, 2023 and December 31, 2023, the Company had the following assets and liabilities measured at fair value in its Consolidated Balance Sheets (excluding assets for which the fair value is measured using net asset value per share):

	Fair Value Measurements Using:
	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
March 31, 2024
Assets:
Available-for-sale securities (1)	$	0.8	$	0.8	$	—	$	—
Derivatives	8.5		—		8.5		—
Total assets	$	9.3	$	0.8	$	8.5	$	—
Liabilities:
Derivatives	$	2.9	$	—	$	2.9	$	—
Option agreement	1.7		—		—		1.7
Total liabilities	$	4.6	$	—	$	2.9	$	1.7
April 2, 2023
Assets:
Available-for-sale securities (1)	$	1.3	$	1.3	$	—	$	—
Derivatives	3.2		—		3.2		—
Total assets	$	4.5	$	1.3	$	3.2	$	—
Liabilities:
Derivatives	$	5.2	$	—	$	5.2	$	—
Option agreement	1.7		—		—		1.7
Total liabilities	$	6.9	$	—	$	5.2	$	1.7
December 31, 2023
Assets:
Available-for-sale securities (1)	$	1.1	$	1.1	$	—	$	—
Derivatives	0.7		—		0.7		—
Total assets	$	1.8	$	1.1	$	0.7	$	—
Liabilities:
Derivatives	$	3.9	$	—	$	3.9	$	—
Option agreement	1.7		—		—		1.7
Total Liabilities	$	5.6	$	—	$	3.9	$	1.7

(1) Available-for-sale securities include equity securities of one company quoted on an active public market.